Search keyWord :

Jia Xudong, partner of Fintopia, emphasized the importance of three dimensions for financial technology to go global

BEIJING,May 24,2024-- A news report from ifeng.com: Recently,the Alibaba Cloud International Summit,with the core theme of "Orange Cloud Going Global,New Journey of Financial Technology",was

May 30, 2024

CNOOC Limited Subsidiaries Signed EPCCs with MIREME and ENH

HONG KONG,May 24,2024-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) announces its wholly owned subsidiaries have entered into petroleum explo

May 30, 2024

Antengene To Present One Oral and Four Abstracts at ASCO 2024

Oral Presentation：a Phase II study of ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in patients with cervical cancer

May 30, 2024

Busting fear barrier about hormone replacement therapy in new era of menopause management

MANILA,Philippines,May 24,2024-- Millions of women around the world continue to suffer unnecessarily from the physical and psychological effects of the menopause because of "mistaken fears"

May 30, 2024

URBAN SPORTS AND STREET ARTS MEET IN SINGAPORE AS PART OF A GLOBAL WARM-UP TO THE PARIS 2024 OLYMPIC GAMES

The unique event,which is among the first global events created to build excitement for the upcoming Olympic Games,sees French andSingaporeans athletes and artists coming together to revitalise the ic

May 30, 2024

Friso Launches #MovetoGoodPoop Movement to Champion Good Gut Health in Children with Music and Storytelling

Homegrown singer-songwriter-producer Derrick Hoh announced as Friso Brand Ambassador for 2024/25 SINGAPORE,May 24,2024--Friso,a leading nutrition formula milk brand with over 150 years of Dutch dairy

May 30, 2024

Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting

The ELECTRA and ELEVATE studies were designed to overcome different resistance mechanisms and improve patient outcomes with oral-oral combination options.

May 30, 2024

Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024

Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression,including in patients with PD-L1 CPS<5.

May 30, 2024

Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024

Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression,including in patients with PD-L1 CPS<5.

May 30, 2024

Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Antitumor efficacy of sunvozertinib was observed in patients regardless of baseline EGFR exon20ins status in plasma ctDNA.

May 30, 2024

1 ... 1213 1214 1215 1216 1217 1218 1219 ... 1255

Singapore Technology Information: Your Source for Tech, AI, Aerospace, Biotech News

Singapore Technology Information is an advanced technology news portal. Committed to reporting on the latest developments in technology, artificial intelligence, biotechnology, data and other fields.